SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $56,863,000 | +15.5% | 583,000 | +9.9% | 0.01% | +20.0% |
| Q4 2014 | $49,236,000 | +25.6% | 530,650 | -6.9% | 0.01% | +25.0% |
| Q3 2014 | $39,210,000 | -26.9% | 570,042 | +11.4% | 0.00% | -33.3% |
| Q2 2014 | $53,628,000 | +23.9% | 511,726 | -1.9% | 0.01% | +20.0% |
| Q1 2014 | $43,286,000 | -12.5% | 521,767 | -39.0% | 0.01% | +66.7% |
| Q4 2013 | $49,476,000 | +64.0% | 855,333 | +79.6% | 0.00% | -25.0% |
| Q3 2013 | $30,162,000 | +61.9% | 476,363 | +7.4% | 0.00% | +100.0% |
| Q2 2013 | $18,628,000 | – | 443,595 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|